TIAA FSB’s Elevance Health ELV Stock Holding History

TIAA FSB’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$18.2M	Sell	40,939 -2,986	-7%	-$1.38M	0.07%	121
2023 Q1	$20.2M	Buy	43,925 +1,348	+3%	+$642K	0.07%	110
2022 Q4	$21.8M	Sell	42,577 -2,196	-5%	-$1.12M	0.09%	109
2022 Q3	$20.3M	Sell	44,773 -325	-0.7%	-$156K	0.09%	105
2022 Q2	$21.8M	Sell	45,098 -8,553	-16%	-$4.23M	0.09%	106
2022 Q1	$26.3M	Sell	53,651 -1,735	-3%	-$793K	0.09%	92
2021 Q4	$25.6M	Sell	55,386 -1,033	-2%	-$435K	0.08%	97
2021 Q3	$21M	Buy	56,419 +213	+0.4%	+$80.9K	0.07%	104
2021 Q2	$21.5M	Buy	56,206 +6,382	+13%	+$2.44M	0.07%	100
2021 Q1	$17.9M	Buy	+49,824	New	+$16M	0.06%	111
2020 Q2	–	Sell	-45,557	Closed	-$10.3M	–	279
2020 Q1	$10.3M	Buy	45,557 +11,219	+33%	+$3.06M	0.06%	120
2019 Q4	$10.4M	Sell	34,338 -2,656	-7%	-$731K	0.05%	127
2019 Q3	$8.88M	Sell	36,994 -11,473	-24%	-$3.14M	0.05%	125
2019 Q2	$13.7M	Buy	+48,467	New	+$13.2M	0.08%	100

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TIAA FSB's ELV Position: Q2 2023 in Review

TIAA FSB reduced its Elevance Health (ELV) stake by 6.8% in Q2 2023, selling an estimated $1.38M and leaving 40,939 shares worth $18.2M. The position accounts for 0.07% of the portfolio, ranked #121.

TIAA FSB first reported a position in ELV in Q2 2019 and has held it in 14 quarters since. The position peaked at $26.3M in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

TIAA FSB held 40,939 shares of Elevance Health worth $18.2M as of Q2 2023.
TIAA FSB sold 2,986 Elevance Health shares in Q2 2023, an estimated $1.38M.
Elevance Health made up 0.07% of TIAA FSB's portfolio in Q2 2023, its #121 holding.
TIAA FSB first reported a position in Elevance Health in Q2 2019 and has held it in 14 quarters since.
TIAA FSB's Elevance Health position peaked at $26.3M in Q1 2022.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.